RBC Capital analyst Brian Abrahams maintained a Buy rating on Hookipa Pharma (HOOK) on May 12 and set a price target of $24.00.
The post RBC Capital Believes Hookipa Pharma (HOOK) Wont Stop Here appeared first on Smarter Analyst.
RBC Capital analyst Brian Abrahams maintained a Buy rating on Hookipa ...
https://www.smarteranalyst.com/new-blurbs/rbc-capital-believes-hookipa-pharma-hook-wont-stop-here/#SmarterAnalyst
You must login before you can post a comment.